1. A102 THIOPURINE METABOLITE LEVEL MONITORING LEADS TO INDIVIDUALIZED AND OPTIMIZED THIOPURINE THERAPY IN ADULT INFLAMMATORY BOWEL DISEASE (IBD). (1st March 2018) Authors: Zhu, J; Abraldes, J; Dieleman, L A; Huang, V; Kroeker, K I; Peerani, F; Wong, K; LeGatt, D; Fedorak, R; Halloran, B P Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 1 Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A113 DIAGNOSTIC ACCURACY OF COMPUTED TOMOGRAPHY ENTEROGRAPHY COMPARED TO BALLOON ASSISTED ENDOSCOPY IN CROHN'S DISEASE. (7th March 2023) Authors: Cooper, J; Dang, T; Reeson, M; Dang, J; Dieleman, L; Kroeker, K; Baumgart, D; Wong, K; Peerani, F; Zepeda-Gomez, S; Wasilenko, S; Hoentjen, F; Wiebe, E; Halloran, B Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 6(2023)Supplement 1 Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A116 EFFECTIVENESS OF A REMOTE PATIENT MONITORING PROTOCOL AIMING TO IMPROVE CARE FOR ULCERATIVE COLITIS PATIENTS. (15th March 2019) Authors: Beilman, C L; Lytvyak, E; Garolera Molas, M; Peerani, F; Dieleman, L A; Kroeker, K; Wong, K; Fedorak, R; Halloran, B Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 2(2019)Supplement 2 Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A131 ELECTRONIC HEALTH RECORD–BASED SMARTSETS INTEGRATE VARIOUS ASPECTS OF FLARE MANAGEMENT IN OUTPATIENTS WITH INFLAMMATORY BOWEL DISEASE THEREFORE ENSURING CONTINUITY OF CARE. (1st March 2018) Authors: Lytvyak, E; Devlin, S; Dieleman, L A; Halloran, B P; Huang, V; Kroeker, K I; Panaccione, R; Peerani, F; Wong, K; Fedorak, R Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 1 Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A132 THREE QUARTERS OF INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE INFLIXIMAB THERAPY IN CLINICAL REMISSION SHOW EVIDENCE OF MUCOSAL INFLAMMATION WITH ELEVATED FECAL CALPROTECTIN. (1st March 2018) Authors: Stern, N; Wong, K; Dieleman, L A; Halloran, B P; Huang, V; Kroeker, K I; Peerani, F; van Zanten, S; Fedorak, R Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 1 Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A137 THERAPEUTIC DRUG MONITORING WITH INFLIXIMAB TROUGH LEVELS LEAD TO INCREASED INTERVENTION. (1st March 2018) Authors: Stern, N C; Fedorak, R; Wong, K; Halloran, B P; Dieleman, L A; Huang, V; Peerani, F; Kroeker, K I Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 2 Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A142 INFLAMMATORY BOWEL DISEASE PATIENTS REQUIRE AN INCREASED ADALIMUMAB DRUG LEVEL TO SIMULTANEOUSLY ACHIEVE CLINICAL AND BIOLOGICAL REMISSION. (15th March 2019) Authors: Cookson, T A; Stern, N C; Sutton, R T; Fedorak, R; Halloran, B; Dieleman, L A; Wong, K; Huang, V; Peerani, F; van Zanten, S; Lazarescu, A; Kroeker, K Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 2(2019)Supplement 2 Page Start: 282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A144 AN EXPLORATORY PROSPECTIVE LONGITUDINAL STUDY INTO THE BREASTFEEDING PRACTICES OF WOMEN WITH INFLAMMATORY BOWEL DISEASE. (1st March 2018) Authors: Nguyen, V V; Baker, C; Andrishak, S R; Ambrosio, L; Berga, K; Dieleman, L A; Halloran, B P; Kroeker, K I; Peerani, F; Wong, K; Fedorak, R; Huang, V Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 2 Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A146 THE EFFECTIVENESS OF USTEKINUMAB DOSE ESCALATION IN PATIENTS WITH ULCERATIVE COLITIS. (21st February 2022) Authors: Albino, L; Rosentreter, R; Lu, C; Siffledeen, J; Dieleman, L A; Ma, C; Baugmart, D C; Du, L; Halloran, B; Kroeker, K; Peerani, F; Wong, K Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 5(2022)Supplement 1 Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A157 THE THRESHOLD FOR INFLIXIMAB TROUGH LEVELS LEADING TO DOSE ESCALATION DIFFERS BETWEEN CROHN'S DISEASE AND ULCERATIVE COLITIS. (1st March 2018) Authors: Cookson, T A; Fedorak, R; Halloran, B P; Dieleman, L A; Wong, K; Huang, V; Peerani, F; Kroeker, K I Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 2 Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗